Development of a new recombinant anti-CD30 immunotoxin (CD30L-ETA') for the treatment of Hodgkin's lymphoma
- 30 June 1997
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S22
- https://doi.org/10.1016/s0959-8049(97)89386-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: